Literature DB >> 28877476

mTORC2 Signaling Selectively Regulates the Generation and Function of Tissue-Resident Peritoneal Macrophages.

Min-Hee Oh1, Samuel L Collins2, Im-Hong Sun3, Ada J Tam3, Chirag H Patel3, Matthew L Arwood3, Yee Chan-Li2, Jonathan D Powell3, Maureen R Horton4.   

Abstract

Tissue-resident macrophages play critical roles in sentinel and homeostatic functions as well as in promoting inflammation and immunity. It has become clear that the generation of these cells is highly dependent upon tissue-specific cues derived from the microenvironment that, in turn, regulate unique differentiation programs. Recently, a role for GATA6 has emerged in the differentiation programming of resident peritoneal macrophages. We identify a critical role for mTOR in integrating cues from the tissue microenvironment in regulating differentiation and metabolic reprogramming. Specifically, inhibition of mTORC2 leads to enhanced GATA6 expression in a FOXO1 dependent fashion. Functionally, inhibition of mTORC2 promotes peritoneal resident macrophage generation in the resolution phase during zymosan-induced peritonitis. Also, mTORC2-deficient peritoneal resident macrophages displayed increased functionality and metabolic reprogramming. Notably, mTORC2 activation distinguishes tissue-resident macrophage proliferation and differentiation from that of M2 macrophages. Overall, our data implicate a selective role for mTORC2 in the differentiation of tissue-resident macrophages.
Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AKT; FOXO1; GATA6; mTOR; mTORC2; metabolism; peritoneal macrophage; tissue-resident macrophage

Mesh:

Substances:

Year:  2017        PMID: 28877476      PMCID: PMC5659290          DOI: 10.1016/j.celrep.2017.08.046

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  52 in total

1.  Disruption of mammalian target of rapamycin complex 1 in macrophages decreases chemokine gene expression and atherosclerosis.

Authors:  Ding Ai; Hongfeng Jiang; Marit Westerterp; Andrew J Murphy; Mi Wang; Anjali Ganda; Sandra Abramowicz; Carrie Welch; Felicidad Almazan; Yi Zhu; Yury I Miller; Alan R Tall
Journal:  Circ Res       Date:  2014-03-31       Impact factor: 17.367

Review 2.  Alternative activation of macrophages: an immunologic functional perspective.

Authors:  Fernando O Martinez; Laura Helming; Siamon Gordon
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

3.  PSGL-1 and mTOR regulate translation of ROCK-1 and physiological functions of macrophages.

Authors:  Richard Fox; Thomas Q Nhan; G Lynn Law; David R Morris; W Conrad Liles; Stephen M Schwartz
Journal:  EMBO J       Date:  2007-01-24       Impact factor: 11.598

4.  FRNK negatively regulates IL-4-mediated inflammation.

Authors:  Ritu Sharma; Pina Colarusso; Hong Zhang; Katarzyna M Stevens; Kamala D Patel
Journal:  J Cell Sci       Date:  2014-12-12       Impact factor: 5.285

Review 5.  Immunoregulatory functions of mTOR inhibition.

Authors:  Angus W Thomson; Hēth R Turnquist; Giorgio Raimondi
Journal:  Nat Rev Immunol       Date:  2009-05       Impact factor: 53.106

6.  The TSC-mTOR signaling pathway regulates the innate inflammatory response.

Authors:  Thomas Weichhart; Giuseppina Costantino; Marko Poglitsch; Margit Rosner; Maximilian Zeyda; Karl M Stuhlmeier; Thomas Kolbe; Thomas M Stulnig; Walter H Hörl; Markus Hengstschläger; Mathias Müller; Marcus D Säemann
Journal:  Immunity       Date:  2008-10-09       Impact factor: 31.745

7.  Mammalian Target of Rapamycin Complex 2 Controls CD8 T Cell Memory Differentiation in a Foxo1-Dependent Manner.

Authors:  Lianjun Zhang; Benjamin O Tschumi; Isabel C Lopez-Mejia; Susanne G Oberle; Marten Meyer; Guerric Samson; Markus A Rüegg; Michael N Hall; Lluis Fajas; Dietmar Zehn; Jean-Pierre Mach; Alena Donda; Pedro Romero
Journal:  Cell Rep       Date:  2016-01-21       Impact factor: 9.423

Review 8.  The M1 and M2 paradigm of macrophage activation: time for reassessment.

Authors:  Fernando O Martinez; Siamon Gordon
Journal:  F1000Prime Rep       Date:  2014-03-03

9.  Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages.

Authors:  Stanley Ching-Cheng Huang; Bart Everts; Yulia Ivanova; David O'Sullivan; Marcia Nascimento; Amber M Smith; Wandy Beatty; Latisha Love-Gregory; Wing Y Lam; Christina M O'Neill; Cong Yan; Hong Du; Nada A Abumrad; Joseph F Urban; Maxim N Artyomov; Erika L Pearce; Edward J Pearce
Journal:  Nat Immunol       Date:  2014-08-03       Impact factor: 25.606

10.  The AGC kinase SGK1 regulates TH1 and TH2 differentiation downstream of the mTORC2 complex.

Authors:  Emily B Heikamp; Chirag H Patel; Sam Collins; Adam Waickman; Min-Hee Oh; Im-Hong Sun; Peter Illei; Archna Sharma; Aniko Naray-Fejes-Toth; Geza Fejes-Toth; Jyoti Misra-Sen; Maureen R Horton; Jonathan D Powell
Journal:  Nat Immunol       Date:  2014-04-06       Impact factor: 25.606

View more
  22 in total

Review 1.  The "other" mTOR complex: New insights into mTORC2 immunobiology and their implications.

Authors:  Helong Dai; Angus W Thomson
Journal:  Am J Transplant       Date:  2019-03-19       Impact factor: 8.086

2.  Inactivation of mTORC2 in macrophages is a signature of colorectal cancer that promotes tumorigenesis.

Authors:  Karl Katholnig; Birgit Schütz; Stephanie D Fritsch; David Schörghofer; Monika Linke; Nyamdelger Sukhbaatar; Julia M Matschinger; Daniela Unterleuthner; Martin Hirtl; Michaela Lang; Merima Herac; Andreas Spittler; Andreas Bergthaler; Gernot Schabbauer; Michael Bergmann; Helmut Dolznig; Markus Hengstschläger; Mark A Magnuson; Mario Mikula; Thomas Weichhart
Journal:  JCI Insight       Date:  2019-10-17

3.  Macrophage monocarboxylate transporter 1 promotes peripheral nerve regeneration after injury in mice.

Authors:  Mithilesh Kumar Jha; Joseph V Passero; Atul Rawat; Xanthe Heifetz Ament; Fang Yang; Svetlana Vidensky; Samuel L Collins; Maureen R Horton; Ahmet Hoke; Guy A Rutter; Alban Latremoliere; Jeffrey D Rothstein; Brett M Morrison
Journal:  J Clin Invest       Date:  2021-11-01       Impact factor: 14.808

4.  Mitophagy-dependent macrophage reprogramming protects against kidney fibrosis.

Authors:  Divya Bhatia; Kuei-Pin Chung; Kiichi Nakahira; Edwin Patino; Michelle C Rice; Lisa K Torres; Thangamani Muthukumar; Augustine Mk Choi; Oleh M Akchurin; Mary E Choi
Journal:  JCI Insight       Date:  2019-12-05

5.  Role of Overexpressed Transcription Factor FOXO1 in Fatal Cardiovascular Septal Defects in Patau Syndrome: Molecular and Therapeutic Strategies.

Authors:  Adel Abuzenadah; Saad Al-Saedi; Sajjad Karim; Mohammed Al-Qahtani
Journal:  Int J Mol Sci       Date:  2018-11-10       Impact factor: 5.923

Review 6.  Understanding the Biology of Self-Renewing Macrophages.

Authors:  Tamás Röszer
Journal:  Cells       Date:  2018-08-09       Impact factor: 6.600

7.  mTORC2 Deficiency Alters the Metabolic Profile of Conventional Dendritic Cells.

Authors:  Alicia R Watson; Helong Dai; Yawen Zheng; Ryosuke Nakano; Anastasios D Giannou; Ashley V Menk; Donna B Stolz; Greg M Delgoffe; Angus W Thomson
Journal:  Front Immunol       Date:  2019-07-02       Impact factor: 7.561

8.  Lipid droplet-dependent fatty acid metabolism controls the immune suppressive phenotype of tumor-associated macrophages.

Authors:  Hao Wu; Yijie Han; Yasmina Rodriguez Sillke; Hongzhang Deng; Sophiya Siddiqui; Christoph Treese; Franziska Schmidt; Marie Friedrich; Jacqueline Keye; Jiajia Wan; Yue Qin; Anja A Kühl; Zhihai Qin; Britta Siegmund; Rainer Glauben
Journal:  EMBO Mol Med       Date:  2019-10-10       Impact factor: 12.137

9.  Loss of Rictor in Monocyte/Macrophages Suppresses Their Proliferation and Viability Reducing Atherosclerosis in LDLR Null Mice.

Authors:  Vladimir R Babaev; Jiansheng Huang; Lei Ding; Youmin Zhang; James M May; MacRae F Linton
Journal:  Front Immunol       Date:  2018-02-13       Impact factor: 7.561

Review 10.  Diversity and environmental adaptation of phagocytic cell metabolism.

Authors:  Luke C Davies; Christopher M Rice; Daniel W McVicar; Jonathan M Weiss
Journal:  J Leukoc Biol       Date:  2018-09-14       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.